TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32163181 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 32164626 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32164626 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32164626 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 32164691 — Surrogate Endpoint (SUR): Blood pressure
Study 32164704 — Surrogate Endpoint (SUR): Bone mineral density
Study 32164884 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 32164981 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 32164981 — Surrogate Endpoint (SUR): Bone mineral density
Study 32165065 — Predictive Biomarker (PRD): GSC mRNA
Genes: GSC
Study 32165065 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 32166305 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 32170554 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32171061 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 32171104 — Predictive Biomarker (PRD): SOX21 mRNA
Genes: SOX21; SOX25; SOXA
Study 32172489 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study 32174840 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 32175617 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 32176787 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32178676 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32178676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32180164 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32182156 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 32182156 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32182364 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32182949 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 32184112 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32184340 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32188473 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 32188473 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32188473 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 32188473 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 32188508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32188704 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32190333 — Surrogate Endpoint (SUR): Blood pressure
Study 32191645 — Predictive Biomarker (PRD): INSR mRNA
Genes: INSR
Study 32195186 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32195932 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32197614 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32197630 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32199451 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 32199466 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32200138 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32200714 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 32201274 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32201506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32201506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32203069 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32203069 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32203306 — Monitoring Biomarker (MOI): Cell-free DNA
Study 32203306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 32203698 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 32203698 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 32205016 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 32205016 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32205016 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 32205068 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32205128 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 32205328 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32206779 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 32206779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32206976 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 32208121 — Surrogate Endpoint (SUR): Blood pressure
Study 32208957 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 32208957 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study 32209572 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32209584 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 32210181 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 32210181 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32210458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32210458 — Surrogate Endpoint (SUR): Bone mineral density
Study 32210548 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32210906 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32212002 — Predictive Biomarker (PRD): SERPINA7 mRNA
Genes: SERPINA7; TBG
Study 32212910 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study 32213479 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32213479 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32213649 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32213860 — Surrogate Endpoint (SUR): Blood pressure
Study 32216750 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 32219330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32219431 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 32221675 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32223334 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32223937 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 32223937 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 32223937 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study 32224030 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 32224416 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32226634 — Surrogate Endpoint (SUR): Blood pressure
Study 32231244 — Predictive Biomarker (PRD): NFKB1 mRNA
Genes: NFKB1
Study 32232095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32232175 — Surrogate Endpoint (SUR): Blood pressure
Study 32232325 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study 32232327 — Predictive Biomarker (PRD): MSX1 mRNA
Genes: MSX1; HOX7
Study 32232380 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32232380 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32232380 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32232380 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32232380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32232380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32232380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32232640 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32232640 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32233700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32234045 — Predictive Biomarker (PRD): IGF2R mRNA
Genes: IGF2R; MPRI
Study 32234708 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32234848 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32236416 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32236441 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 32236525 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32236732 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32236819 — Surrogate Endpoint (SUR): Serum calcium
Study 32236861 — Predictive Biomarker (PRD): OMA1 mRNA
Genes: OMA1; MPRP1
Study 32237015 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 32237015 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32238341 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study 32238343 — Surrogate Endpoint (SUR): Blood pressure
Study 32238515 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32238921 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 32239319 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32240454 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32240629 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32240796 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32242358 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32242358 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32243941 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32245502 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32245502 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 32248659 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 32248659 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 32248659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32248819 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 32250312 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 32250517 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32250517 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32252809 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 32252809 — Predictive Biomarker (PRD): IFI27 mRNA
Genes: IFI27
Study 32252809 — Predictive Biomarker (PRD): IFIT1 mRNA
Genes: IFIT1; G10P1; IFI56; IFNAI1; ISG56
Study 32253717 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 32256115 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32258443 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32259077 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32268367 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32269053 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 32269051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32269142 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 32269146 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32269146 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32270053 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32270313 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 32270710 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32271353 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32271353 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32271898 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 32271898 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32274380 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32274878 — Surrogate Endpoint (SUR): Serum potassium
Study 32278118 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32278382 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study 32278621 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32278621 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 32279228 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32280821 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32281959 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32285998 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 32286905 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 32287129 — Surrogate Endpoint (SUR): Blood pressure
Study 32289161 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 32290838 — Surrogate Endpoint (SUR): Bone mineral density
Study 32291090 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32291269 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 32291269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study 32293300 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 32293449 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32293574 — Surrogate Endpoint (SUR): Blood pressure
Study 32294529 — Predictive Biomarker (PRD): Microsatellite instability
Study 32296873 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 32296873 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32296873 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study 32296969 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32297284 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32298429 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32301258 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 32303612 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32304462 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32304462 — Surrogate Endpoint (SUR): Blood pressure
Study 32304877 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 32306096 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32306096 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 32306296 — Surrogate Endpoint (SUR): Blood pressure
Study 32307017 — Safety Biomarker (SAF): Hyaluronic acid
Study 32307533 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32307533 — Surrogate Endpoint (SUR): Blood pressure
Study 32307692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32307692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32307692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32308367 — Surrogate Endpoint (SUR): Blood pressure
Study 32308505 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 32309426 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32310851 — Predictive Biomarker (PRD): SLC25A20 mRNA
Genes: SLC25A20; CAC; CACT
Study 32312893 — Predictive Biomarker (PRD): RASGRF1 mRNA
Genes: RASGRF1; CDC25; GNRP; GRF1
Study 32314268 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32314268 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32314268 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 32314973 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study 32314974 — Surrogate Endpoint (SUR): Blood pressure
Study 32315306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 32318062 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 32318621 — Predictive Biomarker (PRD): SIGMAR1 mRNA
Genes: SIGMAR1; OPRS1; SRBP; AAG8
Study 32318641 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32318647 — Predictive Biomarker (PRD): TACR3 mRNA
Genes: TACR3; NK3R; TAC3R
Study 32320048 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32324927 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32324981 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32325220 — Predictive Biomarker (PRD): DPEP3 mRNA
Genes: DPEP3; UNQ834/PRO1772
Study 32325220 — Predictive Biomarker (PRD): DPEP1 mRNA
Genes: DPEP1; MDP; RDP
Study 32325220 — Predictive Biomarker (PRD): DPEP2 mRNA
Genes: DPEP2; UNQ284/PRO323
Study 32325480 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 32327472 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 32327472 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32327479 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32328307 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 32328307 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32328660 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32328953 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32329200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 32330099 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study 32330242 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32331767 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 32331936 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32331936 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32333853 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32333930 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32334566 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32335374 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32335525 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 32337059 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 32337094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32337094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32337496 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32337496 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32338094 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32339189 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32339368 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32339368 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 32341039 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32343640 — Predictive Biomarker (PRD): Microsatellite instability
Study 32344248 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32344248 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 32347917 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study 32348254 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 32350119 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 32350119 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 32350119 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 32350119 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study 32350119 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 32350119 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 32350119 — Predictive Biomarker (PRD): TBX21 mRNA
Genes: TBX21; TBET; TBLYM
Study 32350119 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 32350119 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 32350119 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 32352498 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32353110 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32353599 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32355493 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 32355819 — Predictive Biomarker (PRD): GCLM mRNA
Genes: GCLM; GLCLR
Study 32355819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study 32357207 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 32357207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32357207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32357901 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 32357963 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP